Literature DB >> 11039416

Endolaser around macular hole in the management of associated retinal detachment in highly myopic eyes.

A K Kwok1, L L Cheng, L Gopal, T Sharma, D S Lam.   

Abstract

PURPOSE: To analyze the role of endolaser around macular hole in managing associated retinal detachment in patients with high myopia.
METHODS: Review of medical records of 25 consecutive eyes of 25 patients with at least 5.00 diopters of myopia who underwent primary pars plana vitrectomy and fluid-gas exchange. In the first half of the study period, one row of contiguous argon green endolaser was routinely applied over the retinal edge of the macular hole (EL group). In the second half of the study period, endolaser was not applied around any macular hole (NEL group). Demographic information, intraoperative and postoperative complications, and final visual acuities and retinal reattachment rates were studied.
RESULTS: The mean (+/-SD) refractive error was -11.8 +/- -3.5 diopters (D) for the EL group and -11.6 +/- -5.4 D for the NEL group. The mean axial length was 29.0 +/- 1.8 mm for the EL group and 28.3 +/- 1.7 mm for the NEL group. The primary anatomic success was 62.5% (10/16) and 77.8% (7/9) in the EL and NEL groups, respectively. No statistically significant difference was found in preoperative, postoperative, or change in best-corrected visual acuities between the two groups.
CONCLUSION: Endolaser around the macular hole after pars plana vitrectomy and internal gas tamponade may not affect the anatomic or visual outcome in primary retinal detachment secondary to a highly myopic macular hole.

Entities:  

Mesh:

Year:  2000        PMID: 11039416     DOI: 10.1097/00006982-200009000-00002

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  1000 cSt silicone oil vs heavy silicone oil as intraocular tamponade in retinal detachment associated to myopic macular hole.

Authors:  Maurizio Mete; Barbara Parolini; Emilia Maggio; Grazia Pertile
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-16       Impact factor: 3.117

2.  Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia.

Authors:  Sebastian Wolf
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

3.  Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study.

Authors:  A K H Kwok; T Y Y Lai
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

4.  A novel episcleral macular buckling: wire-strengthened sponge exoplant for recurrent macular hole and retinal detachment in high myopic eyes.

Authors:  Hassan A Mortada
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013

5.  Inverted ILM Flap for the Treatment of Myopic Macular Holes: Healing Processes and Morphological Changes in Comparison with Complete ILM Removal.

Authors:  Maurizio Mete; Alessandro Alfano; Emilia Maggio; Massimo Guerriero; Grazia Pertile
Journal:  J Ophthalmol       Date:  2019-06-02       Impact factor: 1.909

6.  Full-thickness macular hole formation in proliferative diabetic retinopathy.

Authors:  Mei-Chi Tsui; Yi-Ting Hsieh; Tso-Ting Lai; Chun-Ting Lai; Hsuan-Chieh Lin; Tzyy-Chang Ho; Chang-Hao Yang; Chung-May Yang; Lu-Chun Wang
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

7.  A Comparative Study between Vitrectomy with Internal Tamponade and a New Modified Fiber Optic Illuminated Ando Plombe for Cases of Macular Hole Retinal Detachment in Myopic Eyes.

Authors:  Ahmed M Bedda; Ahmed M Abdel Hadi; Muhammad S Abd Al Shafy
Journal:  J Ophthalmol       Date:  2015-10-15       Impact factor: 1.909

Review 8.  Pneumatic retinopexy: patient selection and specific factors.

Authors:  Stephen Stewart; Wing Chan
Journal:  Clin Ophthalmol       Date:  2018-03-16

9.  Development of macular holes in diabetic retinopathy with fibrovascular proliferation: Report of four cases.

Authors:  Chun-Ting Lai; Chung-May Yang
Journal:  Taiwan J Ophthalmol       Date:  2015-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.